 | • レポートコード：GIR201107297 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、帯状疱疹後神経痛薬の世界市場を調査対象にし、帯状疱疹後神経痛薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（抗けいれん薬、抗うつ薬、オピオイド、その他）、用途別分析（病院薬局、オンライン薬局、小売薬局）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Depomed、Pfizer、Daiichi Sankyo ・メーカー別販売量、売上、市場シェア ・帯状疱疹後神経痛薬の地域別市場分析 ・帯状疱疹後神経痛薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・帯状疱疹後神経痛薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・帯状疱疹後神経痛薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・帯状疱疹後神経痛薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・帯状疱疹後神経痛薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・帯状疱疹後神経痛薬の種類別市場規模2015-2020：抗けいれん薬、抗うつ薬、オピオイド、その他 ・帯状疱疹後神経痛薬の用途別市場規模2015-2020：病院薬局、オンライン薬局、小売薬局 ・帯状疱疹後神経痛薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Post Herpetic Neuralgia Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Post Herpetic Neuralgia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Post Herpetic Neuralgia Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Post Herpetic Neuralgia Drugs market has been segmented into
Anticonvulsants
Antidepressants
Opioids
Others
By Application, Post Herpetic Neuralgia Drugs has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Post Herpetic Neuralgia Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Post Herpetic Neuralgia Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Post Herpetic Neuralgia Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Post Herpetic Neuralgia Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Post Herpetic Neuralgia Drugs Market Share Analysis
Post Herpetic Neuralgia Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Post Herpetic Neuralgia Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Post Herpetic Neuralgia Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Post Herpetic Neuralgia Drugs are:
Depomed
Pfizer
Daiichi Sankyo
Among other players domestic and global, Post Herpetic Neuralgia Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Post Herpetic Neuralgia Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Post Herpetic Neuralgia Drugs, with price, sales, revenue and global market share of Post Herpetic Neuralgia Drugs in 2018 and 2019.
Chapter 3, the Post Herpetic Neuralgia Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Post Herpetic Neuralgia Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Post Herpetic Neuralgia Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Post Herpetic Neuralgia Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Post Herpetic Neuralgia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Post Herpetic Neuralgia Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Anticonvulsants
1.2.3 Antidepressants
1.2.4 Opioids
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Post Herpetic Neuralgia Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Overview of Global Post Herpetic Neuralgia Drugs Market
1.4.1 Global Post Herpetic Neuralgia Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Depomed
2.1.1 Depomed Details
2.1.2 Depomed Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Depomed SWOT Analysis
2.1.4 Depomed Product and Services
2.1.5 Depomed Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Daiichi Sankyo
2.3.1 Daiichi Sankyo Details
2.3.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Daiichi Sankyo SWOT Analysis
2.3.4 Daiichi Sankyo Product and Services
2.3.5 Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Post Herpetic Neuralgia Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Post Herpetic Neuralgia Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
4.5 South America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
6.3 UK Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
6.4 France Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Post Herpetic Neuralgia Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Post Herpetic Neuralgia Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
7.5 India Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Post Herpetic Neuralgia Drugs Price by Type (2015-2020)
11 Global Post Herpetic Neuralgia Drugs Market Segment by Application
11.1 Global Post Herpetic Neuralgia Drugs Sales Market Share by Application (2015-2020)
11.2 Global Post Herpetic Neuralgia Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Post Herpetic Neuralgia Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Post Herpetic Neuralgia Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Post Herpetic Neuralgia Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Post Herpetic Neuralgia Drugs Market Forecast (2021-2025)
12.2.2 Europe Post Herpetic Neuralgia Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Post Herpetic Neuralgia Drugs Market Forecast (2021-2025)
12.2.4 South America Post Herpetic Neuralgia Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Post Herpetic Neuralgia Drugs Market Forecast (2021-2025)
12.3 Post Herpetic Neuralgia Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Post Herpetic Neuralgia Drugs Market Share Forecast by Type (2021-2025)
12.4 Post Herpetic Neuralgia Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Post Herpetic Neuralgia Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Post Herpetic Neuralgia Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Post Herpetic Neuralgia Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Post Herpetic Neuralgia Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Depomed Basic Information, Manufacturing Base and Competitors
Table 8. Depomed Post Herpetic Neuralgia Drugs Major Business
Table 9. Depomed Post Herpetic Neuralgia Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Depomed SWOT Analysis
Table 11. Depomed Post Herpetic Neuralgia Drugs Product and Services
Table 12. Depomed Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Post Herpetic Neuralgia Drugs Major Business
Table 15. Pfizer Post Herpetic Neuralgia Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Pfizer SWOT Analysis
Table 17. Pfizer Post Herpetic Neuralgia Drugs Product and Services
Table 18. Pfizer Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo Post Herpetic Neuralgia Drugs Major Business
Table 21. Daiichi Sankyo Post Herpetic Neuralgia Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Daiichi Sankyo SWOT Analysis
Table 23. Daiichi Sankyo Post Herpetic Neuralgia Drugs Product and Services
Table 24. Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global Post Herpetic Neuralgia Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 26. Global Post Herpetic Neuralgia Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global Post Herpetic Neuralgia Drugs Sales by Regions (2015-2020) (K Units)
Table 28. Global Post Herpetic Neuralgia Drugs Sales Market Share by Regions (2015-2020)
Table 29. Global Post Herpetic Neuralgia Drugs Revenue by Regions (2015-2020) (USD Million)
Table 30. North America Post Herpetic Neuralgia Drugs Sales by Countries (2015-2020) (K Units)
Table 31. North America Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2015-2020)
Table 32. North America Post Herpetic Neuralgia Drugs Revenue by Countries (2015-2020) (USD Million)
Table 33. North America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2015-2020)
Table 34. Europe Post Herpetic Neuralgia Drugs Sales by Countries (2015-2020) (K Units)
Table 35. Europe Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2015-2020)
Table 36. Europe Post Herpetic Neuralgia Drugs Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific Post Herpetic Neuralgia Drugs Sales by Regions (2015-2020) (K Units)
Table 38. Asia-Pacific Post Herpetic Neuralgia Drugs Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific Post Herpetic Neuralgia Drugs Revenue by Regions (2015-2020) (USD Million)
Table 40. South America Post Herpetic Neuralgia Drugs Sales by Countries (2015-2020) (K Units)
Table 41. South America Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2015-2020)
Table 42. South America Post Herpetic Neuralgia Drugs Revenue by Countries (2015-2020) (USD Million)
Table 43. South America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Post Herpetic Neuralgia Drugs Sales by Countries (2015-2020) (K Units)
Table 45. Middle East & Africa Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa Post Herpetic Neuralgia Drugs Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2015-2020)
Table 48. Global Post Herpetic Neuralgia Drugs Sales by Type (2015-2020) (K Units)
Table 49. Global Post Herpetic Neuralgia Drugs Sales Share by Type (2015-2020)
Table 50. Global Post Herpetic Neuralgia Drugs Revenue by Type (2015-2020) (USD Million)
Table 51. Global Post Herpetic Neuralgia Drugs Revenue Share by Type (2015-2020)
Table 52. Global Post Herpetic Neuralgia Drugs Sales by Application (2015-2020) (K Units)
Table 53. Global Post Herpetic Neuralgia Drugs Sales Share by Application (2015-2020)
Table 54. Global Post Herpetic Neuralgia Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 55. Global Post Herpetic Neuralgia Drugs Market Share Forecast by Regions (2021-2025)
Table 56. Global Post Herpetic Neuralgia Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 57. Global Post Herpetic Neuralgia Drugs Market Share Forecast by Type (2021-2025)
Table 58. Global Post Herpetic Neuralgia Drugs Sales Forecast by Application (2021-2025)
Table 59. Global Post Herpetic Neuralgia Drugs Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Post Herpetic Neuralgia Drugs Picture
Figure 2. Global Sales Market Share of Post Herpetic Neuralgia Drugs by Type in 2019
Figure 3. Anticonvulsants Picture
Figure 4. Antidepressants Picture
Figure 5. Opioids Picture
Figure 6. Others Picture
Figure 7. Post Herpetic Neuralgia Drugs Sales Market Share by Application in 2018
Figure 8. Hospital Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Global Post Herpetic Neuralgia Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Post Herpetic Neuralgia Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Post Herpetic Neuralgia Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Post Herpetic Neuralgia Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Post Herpetic Neuralgia Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Post Herpetic Neuralgia Drugs Sales Market Share by Countries in 2018
Figure 48. North America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Post Herpetic Neuralgia Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Post Herpetic Neuralgia Drugs Revenue Market Share by Regions 2019
Figure 64. China Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Post Herpetic Neuralgia Drugs Sales Market Share by Countries in 2019
Figure 71. South America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Post Herpetic Neuralgia Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Post Herpetic Neuralgia Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Post Herpetic Neuralgia Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Post Herpetic Neuralgia Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Post Herpetic Neuralgia Drugs Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Post Herpetic Neuralgia Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Post Herpetic Neuralgia Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
帯状疱疹後神経痛治療の世界市場 2020年 Market Overview The global Post Herpetic Neuralgia Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Post Herpet…- 帯状疱疹後神経痛パッチの世界市場 2020年 Market Overview The global Post Herpetic Neuralgia Patches market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Post Herpetic…
- 術後用創傷治療の世界市場 2020年 Market Overview The global Post-Operative Wound Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Post-Operativ…
- 心的外傷後ストレス障害治療の世界市場 2020年 Market Overview The global Post-Traumatic Stress Disorder Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Post…
- 心的外傷後ストレス障害（PTSD）治療薬の世界市場 2020年 Market Overview The global Post-Traumatic Stress Disorder (PTSD) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019…